Marinus Pharmaceuticals Inc

NASDAQ:MRNS   12:30:06 PM EDT
4.94
-0.08 (-1.50%)
Products, Regulatory

Marinus Pharmaceuticals Announces Resumption Of Phase 3 Raise Trial In Status Epilepticus

Published: 05/05/2022 12:58 GMT
Marinus Pharmaceuticals Inc (MRNS) - Marinus Pharmaceuticals Announces Resumption of Phase 3 Raise Trial in Status Epilepticus.
Marinus Pharmaceuticals Inc - Company Continues to Expect Topline Raise Trial Results in Second Half of 2023.
Marinus Pharmaceuticals Inc - Continues to Expand Number of Participating Clinical Trial Sites for Raise Trial in U.S. and Canada.